论文部分内容阅读
目的观察布地奈德联合沙丁胺醇雾化吸入治疗儿童哮喘的临床效果。方法 68例支气管哮喘患儿随机分成对照组和治疗组,各34例,对照组给予常规治疗(吸氧、镇静、止咳、抗感染、补液、纠正酸碱紊乱等)。治疗组在常规治疗基础上给布地奈德联合沙丁胺醇雾化吸入治疗,观察两组患者临床治疗效果。结果治疗组的总有效率94.1%,对照组患儿的总有效率67.6%,治疗组患儿临床效果明显优于对照组,差异具有统计学意义(P<0.05)。结论布地奈德联合沙丁胺醇雾化吸入治疗儿童哮喘的临床效果较显著,能有效改善患儿哮喘症状,值得临床应用推广。
Objective To observe the clinical efficacy of budesonide combined with salbutamol inhalation in the treatment of childhood asthma. Methods A total of 68 children with bronchial asthma were randomly divided into control group and treatment group, 34 cases in each group. The control group was given routine treatment (oxygen, sedation, cough, anti-infection, rehydration, correct acid-base disorders, etc.). The treatment group received budesonide combined with salbutamol inhalation therapy on the basis of routine treatment, and the clinical treatment effect was observed in both groups. Results The total effective rate was 94.1% in the treatment group and 67.6% in the control group. The clinical effect of the treatment group was significantly better than that of the control group, with statistical significance (P <0.05). Conclusion Budesonide combined with salbutamol nebulized inhalation treatment of childhood asthma clinical effect is more significant, can effectively improve children with asthma symptoms, it is worth promoting the clinical application.